Letter to the Editor: The real-world effectiveness of lamotrigine as a mood stabilizer for those with a bipolar II disorder: A pragmatic research study
Restricted accessLetterFirst published online February, 2025
Letter to the Editor: The real-world effectiveness of lamotrigine as a mood stabilizer for those with a bipolar II disorder: A pragmatic research study
AbbasiABCurtisLHCaliffRM (2024) Why should the FDA focus on pragmatic clinical research?Journal of the American Medical Association33: 203–104.
2.
ParkerG (2018) Risks associated with lamotrigine prescription: A review and personal observations. Australasian Psychiatry26: 640–642.
3.
ParkerGMcCrawS (2015) The ‘disconnect’ between initial judgments of lamotrigine vs. its real-world effectiveness in managing bipolar disorder. A tale with wider ramifications. Acta Psychiatrica Scandinavica132: 345–354.
4.
PostR (2019) Management commentary. In: ParkerG (ed.) Bipolar II Disorder. Modelling, Measuring and Managing, 3rd Edition.Cambridge: Cambridge University Press, pp. 255–262.
5.
WangXQXiongJXuWH, et al. (2015) Risk of a lamotrigine-related skin rash: Current meta-analysis and postmarketing cohort analysis. Seizure25: 52–61.
